BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Sionix Corporation Receives Additional Patent Award, Extends Its Intellectual Property Leadership in Dissolved Air Flotation


1/22/2013 9:16:15 AM

LOS ANGELES, CA--(Marketwire - January 22, 2013) - Sionix Corporation (OTCQB: SINX) announced today that it has received a Notice of Allowance for U.S. Patent Application Number 13/029,970 -- "Dissolved Air Flotation System with Bubble Separation System and Method of Use." Sionix has now secured six U.S. patents related to its dissolved air floatation ("DAF") technology that are active, and one provisional patent dealing with water treatment. In addition, Sionix has three DAF patent applications at the U.S. Patent & Trademark Office.

The systems and methods covered by Sionix' latest patent provide for increased air saturation and thus overall increase in efficiency for the operation of the Sionix DAF system.

The Sionix dissolved air flotation equipment is used to clarify water, and may be used for removing suspended solids, organisms, and dissolved solids with the aid of a flocculent. The technology can effectively treat waste water from industrial, municipal, and various agricultural sources, as well as recycling water from oil and gas fracking operations.

In its prior U.S. Patents Nos. 6,921,478, 7,767,080, and 7,033,495, Sionix disclosed a dissolved air flotation system comprising a flocculation tank, a flotation tank, a white water injection system, a skimmer, and a conveyor belt for carrying off the float after it has been skimmed, and a clean water outlet at the bottom of the flotation tank. Experience with the device described in its prior patents has led to various improvements reflected in this latest patent.

Sionix will continue to increase its intellectual property assets through various patent applications in the future with unique proprietary approaches to DAF, and other water treatment technologies.

About Sionix Corporation

Sionix designs innovative and advanced water treatment systems intended for use in energy, government facilities, healthcare facilities, and emergency water supplies during natural disasters, housing development projects, and various industrial processes including subterranean fracturing used in oil and gas drilling. These systems can be located adjacent to contaminated water sites or as a pre-treatment for reverse osmosis and other membrane applications. Industries involved in dairy, agribusiness, meat processing, mining, poultry operations, and many others can benefit from Sionix' cost-effective, easily maintained, portable water treatment systems. For more information about the company, go to www.sionix.com.

Forward-Looking Statements

All statements in this press release that are not statements of historical fact are forward-looking statements, including any projections of earnings, revenue, or other financial items, any statements of the plans, strategies, and objectives of management for future operations, any statements concerning proposed new products, services or developments, any statements regarding future economic conditions or performance, statements of belief and any statements of assumptions underlying any of the foregoing. These statements are based on expectations and assumptions as of the date of this press release and are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements. The risks and uncertainties include, but are not limited to, whether Sionix Corporation can raise capital as and when it needs to, whether the water purification systems will generate significant sales, whether it can compete successfully in its market and industry, and other factors beyond the control of Sionix Corporation, including those detailed from time to time in the reports filed with the Securities and Exchange Commission. Sionix Corporation assumes no obligation and does not intend to update these forward-looking statements.


Company Contact:
Kenneth Calligar
Interim Chief Executive Officer
kcalligar@sionix.com

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES